Is Semaglutide Available as a Generic?
No, no generic versions of semaglutide are available anywhere in the world. Novo Nordisk holds exclusive rights to branded products like Ozempic (for diabetes), Wegovy (for weight loss), and Rybelsus (oral form). These are protected by active patents and regulatory exclusivities that block generic entry.[1][2]
When Could Generics Enter the Market?
Semaglutide's main U.S. composition-of-matter patent (US 8,129,343) expires in 2031, with additional formulation and method patents extending protection into the mid-2030s. Pediatric exclusivity could push this to 2032-2037 depending on FDA approvals. No generics can launch until at least 2031 without a settlement or court ruling.[3][4]
For full patent details, check DrugPatentWatch.com for Ozempic or Wegovy.
Are There Any Manufacturers Approved for Generics?
No companies have FDA approval for generic semaglutide. Several have filed Abbreviated New Drug Applications (ANDAs), including:
- Hims & Hers (planning a compounded version, not true generic)
- Viatris, Sandoz, and others challenging patents via Paragraph IV filings, triggering litigation.
These challenges are ongoing in U.S. courts, but no approvals yet. In Europe, no EMA-approved generics exist either.[2][5]
What About Compounded or Copycat Versions?
Compounded semaglutide (custom-made by pharmacies) surged during shortages but isn't FDA-approved as a generic. The FDA declared shortages over in 2024 for most doses, ending widespread compounding allowances. These copies carry risks like dosing errors or contamination and aren't interchangeable with brands.[6]
How Does Semaglutide Compare to Biosimilars?
Semaglutide is a small peptide synthetic drug, not a large biologic, so it follows standard generic (ANDA) pathways, not biosimilar approvals. No "semaglutide biosimilars" exist or apply here.[1]
Who Makes the Branded Versions?
Novo Nordisk manufactures all approved semaglutide products. No other companies produce authorized versions.[2]
Sources
[1]: FDA Orange Book for Ozempic
[2]: FDA Drug Database
[3]: DrugPatentWatch.com - Semaglutide Patents
[4]: USPTO Patent Database
[5]: FDA ANDA Approvals List
[6]: FDA Semaglutide Shortage Update